Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Laser-assisted Cisplatin + 5-FU for Basal Cell Carcinoma
NCT03541252Phase 2Completed
- Start
- Mar 2018
- Primary completion
- Sep 2019
- Modality
- Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of Cisplatin micelle injection (HA132) and fluorouracil in basal cell carcinoma (BCC). Primary endpoint: Change in Occurence of Local Skin Reaction (LSR) Side Effects TOTAL COMPOSITE SCORE at 3 months. Started Mar 2018; status: completed.
02
Drugs
Cisplatin micelle injection (HA132)fluorouracil
03
Conditions
basal cell carcinoma (BCC)
Beyond the preview
Go deeper on NCT03541252.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03541252.